Posted by Michael Wonder on 21 Feb 2018
EMA publishes agenda for 19-22 February CHMP meeting
22 February 2018 - The EMA has published a draft agenda for this week's CHMP meeting.
The CHMP is due to issue initial opinions for the following technologies:
- Peramivir
- Glibenclamide
- Carmustine
- Beclometasone dipropionate with wformoterol fumarate dihydrate and glycopyrronium bromide
- Andexanet alfa
- Metreleptin
- Neratinib maleate
- Prasugrel
